Literature DB >> 2536539

Altered central alpha 2-adrenoceptor sensitivity in panic disorder.

D J Nutt1.   

Abstract

The possibility that a disorder of brain alpha 2-adrenoceptor sensitivity might contribute to the etiology of panic disorder was examined using a challenge paradigm with the alpha 2-adrenoceptor agonist clonidine. The cardiovascular, psychological, and endocrine actions of 1.5-microgram/kg clonidine hydrochloride given intravenously were assessed in 16 patients and compared with age- and sex-matched controls. Patients with panic disorder showed an increased fall in blood pressure and decreased sedative and endocrine responses as compared with controls. These results suggest that there may be subsensitivity of some, and supersensitivity of other, brain alpha 2-adrenoceptors in panic disorder. In view of the increased cardiovascular responses seen in the present study and other reports of increased responses to the alpha 2-adrenoceptor antagonist yohimbine, there may exist an increased lability (decreased damping) of cardiovascular control mechanisms in panic disorder. Such a dysfunction could contribute to the symptoms of panic attacks, such as dizziness, palpitations, and faintness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536539     DOI: 10.1001/archpsyc.1989.01810020067011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  10 in total

1.  Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder.

Authors:  D S Charney; R B Innis; R S Duman; S W Woods; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 3.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

4.  Melatonin responses to clonidine and yohimbine challenges.

Authors:  S H Kennedy; W Gnam; E Ralevski; G M Brown
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

Review 5.  Psychotraumatology: a two-factor formulation of posttraumatic stress.

Authors:  G S Everly
Journal:  Integr Physiol Behav Sci       Date:  1993 Jul-Sep

6.  Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain.

Authors:  Yukie Kawahara; Hiroshi Kawahara; Fumi Kaneko; Masatoshi Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2007-05-30       Impact factor: 4.530

Review 7.  Panic disorder. Pathophysiology and drug treatment.

Authors:  M R Johnson; R B Lydiard; J C Ballenger
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

8.  No evidence that panic attacks are associated with the white coat effect in hypertension.

Authors:  S J C Davies; P R Jackson; L E Ramsay; P Ghahramani; R L Palmer; J Hippisley-Cox
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738

Review 9.  Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers.

Authors:  Jung Goo Lee; Young Sup Woo; Sung Woo Park; Dae-Hyun Seog; Mi Kyoung Seo; Won-Myong Bahk
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

Review 10.  Interoception and stress.

Authors:  André Schulz; Claus Vögele
Journal:  Front Psychol       Date:  2015-07-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.